Abstract
SARS-CoV-2 infections in childcare and school settings potentially bear occupational risks to educational staff. We analyzed data derived from voluntary, PCR-based screening of childcare educators and teachers attending five testing sites in Berlin, Germany, between June and December 2020.
Within seven months, 17,491 tests were performed (4,458 educators, 13,033 teachers). Participants were largely female (72.9%), and median age was 41 years. Overall, SARS-CoV-2 infection prevalence was 1.2% (95%CI, 1.1-1.4%). Prevalence in educational staff largely resembled community incidence until the start of the second pandemic wave in mid-September 2020, when an unsteady prevalence plateau was reached. Then, infection prevalence in teachers (1.2% [95%CI, 0.8-1.8%]) did not significantly differ from the population prevalence (0.9% [0.6-1.4%]) but it was increased in educators (2.6% [1.6-4.0%]; aOR, 1.6 [1.3-2.0]). Irrespective of occupation, those that reported contact to a confirmed SARS-CoV-2 case outside of work had increased risk of infection (aOR, 3.0 [95%CI, 1.5-5.5]). In a step-wise backwards selection, the best set of associated factors with SARS-CoV-2 infection involved age, occupation, and calendar week.
These results are in line with findings that teachers do not bear an increased risk of SARS-CoV-2 infection, while childcare educators do. Infection control and prevention measures need to be strengthened in child care settings to further reduce respective occupational hazards. At the same time, the private environment appears to be the main source of SARS-CoV-2 infection for educational staff.
Competing Interest Statement
All other authors declare they have no conflict of interests.
TK reports outside the submitted work to have received research grants from the German Joint Committee and the German Ministry of Health. He further reports personal compensation from Eli Lilly & Company, Teva, Total S.E. and the BMJ.
Funding Statement
This study was funded by the Senate of Berlin. The funder had no role in the design and conduct of the study, or in the interpretation of results.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study was performed in line with the principles of the Declaration of Helsinki. Approval was obtained from the ethics committee. The study was reviewed by the ethics committee at Charite Universitaetsmedizin Berlin, Germany (EA1/313/20).
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
The study was approved by the ethics committee of Charité Universitaetsmedizin Berlin.
Data Availability
Corresponding author: Dr. med. Maximilian Gertler; Institute of Tropical Medicine and International Health, Charite Universitaetsmedizin Berlin, Augustenburger Platz 1, 13353 Berlin, Germany; email: maximilian.gertler{at}charite.de
Analysis code is available upon request from Welmoed van Loon, welmoed.van-loon{at}charite.de
